Skip to main navigation Skip to search Skip to main content

Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

  • Sube Banerjee*
  • , Juliet High
  • , Susan Stirling
  • , Lee Shepstone
  • , Ann Marie Swart
  • , Tanya Telling
  • , Catherine Henderson
  • , Clive Ballard
  • , Peter Bentham
  • , Alistair Burns
  • , Nicolas Farina
  • , Chris Fox
  • , Paul Francis
  • , Robert Howard
  • , Martin Knapp
  • , Iracema Leroi
  • , Gill Livingston
  • , Ramin Nilforooshan
  • , Shirley Nurock
  • , John O'Brien
  • Annabel Price, Alan J. Thomas, Naji Tabet
*Corresponding author for this work
  • University of East Anglia
  • University of Sussex
  • The London School of Economics and Political Science
  • University of Exeter
  • Birmingham and Solihull Mental Health NHS Foundation Trust
  • University of Manchester
  • University College London
  • Trinity College Dublin
  • Surrey and Borders Partnership NHS Foundation Trust
  • University of Cambridge
  • Cambridgeshire and Peterborough NHS Foundation Trust
  • Newcastle University

Research output: Contribution to journalArticlepeer-review

14 Downloads (Pure)
Original languageEnglish
Pages (from-to)1487-1497
Number of pages0
JournalThe Lancet
Volume398
Issue number10310
Early online date21 Oct 2021
DOIs
Publication statusPublished - 21 Oct 2021

Cite this